Clinical Trial Update: Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

An update on a Phase 3 clinical trial evaluating thymopentin in patients after curative resection of small hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Thymopentin (thymopentin)

Snippet

Sponsor: Fudan University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN